Global Collaborations & Government Partnerships

Between 2019 and 2023, SmartLabs expanded from an operating company into a reference model for national and regional innovation policy.

Coverage from Commercial Times, Digitimes, and China Times first introduced SmartLabs' flexible laboratory concept to Asian biotech and manufacturing audiences. Taiwan's Ministry of Economic Affairs and National Science and Technology Council later profiled the model as an example of how private innovation can accelerate national science and technology agendas.

Parallel to that global interest, SmartLabs was invited into city- and state-level partnerships in the United States. That same perspective informed my December 8, 2021 statement before the 117th Congress on The Future of Biomedicine, outlining how modular, digitally connected laboratories strengthen the nation's biomedical supply chain and accelerate translational science.